130 related articles for article (PubMed ID: 37751773)
1. Subjective cognitive changes following premenopausal risk-reducing bilateral salpingo-oophorectomy.
Ramachandra A; Thomas EHX; Vincent AJ; Hickey M; Warren N; Kulkarni J; Forrest LE; Bojadzieva J; Campbell A; Gurvich C
Climacteric; 2023 Dec; 26(6):625-631. PubMed ID: 37751773
[TBL] [Abstract][Full Text] [Related]
2. Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration.
Zeydan B; Tosakulwong N; Schwarz CG; Senjem ML; Gunter JL; Reid RI; Gazzuola Rocca L; Lesnick TG; Smith CY; Bailey KR; Lowe VJ; Roberts RO; Jack CR; Petersen RC; Miller VM; Mielke MM; Rocca WA; Kantarci K
JAMA Neurol; 2019 Jan; 76(1):95-100. PubMed ID: 30326011
[TBL] [Abstract][Full Text] [Related]
3. Short-term impact of surgically induced menopause on cognitive function and wellbeing in women at high risk for ovarian cancer following risk-reducing bilateral salpingo-oophorectomy.
Chang H; Kamara D; Bresee C; Lester J; Cass I
Menopause; 2020 Dec; 28(4):354-359. PubMed ID: 33350669
[TBL] [Abstract][Full Text] [Related]
4. What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women.
Hickey M; Trainer A; Braat S; Davey MA; Krejany E; Wark J
BMJ Open; 2017 Nov; 7(11):e018758. PubMed ID: 29138210
[TBL] [Abstract][Full Text] [Related]
5. BRCA carriers after risk-reducing bilateral salpingo-oophorectomy: menopausal hormone therapy knowledge gaps, and the impact of physicians' recommendations.
Armon S; Miron-Shatz T; Mor P; Tomer A; Levy-Lahad E; Michaelson-Cohen R; Srebnik N
Climacteric; 2023 Apr; 26(2):154-160. PubMed ID: 36866779
[TBL] [Abstract][Full Text] [Related]
6. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
Benshushan A; Rojansky N; Chaviv M; Arbel-Alon S; Benmeir A; Imbar T; Brzezinski A
Climacteric; 2009 Oct; 12(5):404-9. PubMed ID: 19479488
[TBL] [Abstract][Full Text] [Related]
7. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
Hall E; Finch A; Jacobson M; Rosen B; Metcalfe K; Sun P; Narod SA; Kotsopoulos J
Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
[TBL] [Abstract][Full Text] [Related]
8. What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
Hickey M; Moss KM; Brand A; Wrede CD; Domchek SM; Meiser B; Mishra GD; Joffe H
Gynecol Oncol; 2021 May; 161(2):527-534. PubMed ID: 33583580
[TBL] [Abstract][Full Text] [Related]
9. Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
Terra L; Beekman MJ; Engelhardt EG; Heemskerk-Gerritsen BAM; van Beurden M; Roeters van Lennep JE; van Doorn HC; de Hullu JA; Van Dorst EBL; Mom CH; Slangen BFM; Gaarenstroom KN; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; Van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; Aaronson NK; Mourits MJE; van Leeuwen FE
Am J Obstet Gynecol; 2023 Apr; 228(4):440.e1-440.e20. PubMed ID: 36403862
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
Terra L; Lee Meeuw Kjoe PR; Agelink van Rentergem JA; Beekman MJ; Heemskerk-Gerritsen BAM; van Beurden M; Roeters van Lennep JE; van Doorn HC; de Hullu JA; Mourits MJE; van Dorst EBL; Mom CH; Slangen BFM; Gaarenstroom KN; van der Kolk LE; Collée JM; Wevers MR; Ausems MGEM; van Engelen K; van de Beek I; Berger LPV; van Asperen CJ; Gomez Garcia EB; Maas AHEM; Hooning MJ; van der Wall E; van Leeuwen FE; Schagen SB
BJOG; 2023 Jul; 130(8):968-977. PubMed ID: 36715559
[TBL] [Abstract][Full Text] [Related]
11. WHAM-A Prospective Study of Weight and Body Composition After Risk-Reducing Bilateral Salpingo-oophorectomy.
Price SAL; Finch S; Krejany E; Jiang H; Kale A; Domchek S; Wrede D; Wark JD; Hickey M
J Clin Endocrinol Metab; 2023 Dec; 109(1):e397-e405. PubMed ID: 37410931
[TBL] [Abstract][Full Text] [Related]
12. What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomy.
Moss KM; Mishra GD; Krejany EO; Hickey M
Gynecol Oncol; 2022 Oct; 167(1):58-64. PubMed ID: 35933227
[TBL] [Abstract][Full Text] [Related]
13. Patient reported experiences following laparoscopic prophylactic bilateral salpingo-oophorectomy or salpingectomy in an ambulatory care hospital.
Trister R; Jacobson M; Nguyen P; Sobel M; Allen L; Narod SA; Kotsopoulos J
Fam Cancer; 2021 Apr; 20(2):103-110. PubMed ID: 32964297
[TBL] [Abstract][Full Text] [Related]
14. Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
Johansen N; Liavaag AH; Iversen OE; Dørum A; Braaten T; Michelsen TM
Acta Obstet Gynecol Scand; 2017 May; 96(5):547-555. PubMed ID: 28236297
[TBL] [Abstract][Full Text] [Related]
15. Surgical decision making in premenopausal
Gaba F; Goyal S; Marks D; Chandrasekaran D; Evans O; Robbani S; Tyson C; Legood R; Saridogan E; McCluggage WG; Hanson H; Singh N; Evans DG; Menon U; Manchanda R;
J Med Genet; 2022 Feb; 59(2):122-132. PubMed ID: 33568437
[TBL] [Abstract][Full Text] [Related]
16. BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study.
Lynce F; Schlam I; Geng X; Peshkin BN; Friedman S; Dutil J; Nahleh Z; Campos C; Ricker C; Rodriguez P; Denduluri N; Ahn J; Isaacs C; Graves KD
J Genet Couns; 2021 Apr; 30(2):383-393. PubMed ID: 33010199
[TBL] [Abstract][Full Text] [Related]
17. Risk-reducing bilateral salpingo-oophorectomy and sexual health: a qualitative study.
Brotto LA; Branco N; Dunkley C; McCullum M; McAlpine JN
J Obstet Gynaecol Can; 2012 Feb; 34(2):172-178. PubMed ID: 22340066
[TBL] [Abstract][Full Text] [Related]
18. Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis.
Hermens M; van Altena AM; Bulten J; van Vliet HAAM; Siebers AG; Bekkers RLM
Fertil Steril; 2022 May; 117(5):938-945. PubMed ID: 35300832
[TBL] [Abstract][Full Text] [Related]
19. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
[TBL] [Abstract][Full Text] [Related]
20. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME
Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
